We have located links that may give you full text access.
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: The ESC-EORP CICD-LT registry.
European Journal of Preventive Cardiology 2022 June 3
BACKGROUND: In Europe, global data on guideline adherence, geographic variations and determinants of clinical events in Chronic coronary syndrome (CCS) patients remain suboptimal.
DESIGN: The European Society of Cardiology (ESC) EORP CICD-LT registry is a prospective European registry, was designed to describe the profile, management and outcomes of patients with CCS across the ESC countries.
METHODS: We aimed to investigate clinical events at one-year follow-up from the ESC EORP CICD-LT Registry.
RESULTS: One-year outcomes of 6655 patients from the 9174 recruited in this European registry were analyzed. Overall, 168 patients (2.5%) died, mostly from CV causes (n= 97, 1.5%). Northern Europe had the lowest CV mortality rate, while southern Europe had the highest (0.5% vs 2.0%, p= 0.04). Women had a higher rate of CV mortality compared with men (2.0% vs 1.3%, p = 0.02). During follow-up, 1606 patients (27.1%) were hospitalized at least once, predominantly for CV indications (n = 1220, 20.6%). Among the population with measured LDL-cholesterol level at one-year, 1434 patients (66.5%) were above the recommended target. Age, history of atrial fibrillation, previous stroke, liver disease, chronic obstructive pulmonary disease or asthma, increased serum creatinine and impaired left ventricular function were associated with an increased risk of CV death or hospitalization.
CONCLUSION: In the CICD registry, the majority of patients with CCS have uncontrolled CV risk factors. The one year mortality rate is low, but these patients are frequently hospitalized for CV causes. Early identification of comorbidities may represent an opportunity for enhanced care and better outcomes.
DESIGN: The European Society of Cardiology (ESC) EORP CICD-LT registry is a prospective European registry, was designed to describe the profile, management and outcomes of patients with CCS across the ESC countries.
METHODS: We aimed to investigate clinical events at one-year follow-up from the ESC EORP CICD-LT Registry.
RESULTS: One-year outcomes of 6655 patients from the 9174 recruited in this European registry were analyzed. Overall, 168 patients (2.5%) died, mostly from CV causes (n= 97, 1.5%). Northern Europe had the lowest CV mortality rate, while southern Europe had the highest (0.5% vs 2.0%, p= 0.04). Women had a higher rate of CV mortality compared with men (2.0% vs 1.3%, p = 0.02). During follow-up, 1606 patients (27.1%) were hospitalized at least once, predominantly for CV indications (n = 1220, 20.6%). Among the population with measured LDL-cholesterol level at one-year, 1434 patients (66.5%) were above the recommended target. Age, history of atrial fibrillation, previous stroke, liver disease, chronic obstructive pulmonary disease or asthma, increased serum creatinine and impaired left ventricular function were associated with an increased risk of CV death or hospitalization.
CONCLUSION: In the CICD registry, the majority of patients with CCS have uncontrolled CV risk factors. The one year mortality rate is low, but these patients are frequently hospitalized for CV causes. Early identification of comorbidities may represent an opportunity for enhanced care and better outcomes.
Full text links
Related Resources
Trending Papers
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis.Alimentary Pharmacology & Therapeutics 2024 March 26
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app